The beta-blocker controversy in the management of hypertension
dc.contributor.author | Wijesiriwardena, B. | en_US |
dc.date.accessioned | 2013-11-27T06:30:47Z | |
dc.date.available | 2013-11-27T06:30:47Z | |
dc.date.issued | 2005 | en_US |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 38(1):p.1 | en_US |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/10117 | |
dc.publisher | The Ceylon College of Physicians. Rajagiriya | en_US |
dc.subject | Medical Sciences | en_US |
dc.subject | Hypertension | en_US |
dc.subject | Disease management | en_US |
dc.subject | Drug therapy | en_US |
dc.subject | Beta-blocker therapy | en_US |
dc.subject | Drug effects | en_US |
dc.subject | Pharmacology | en_US |
dc.title | The beta-blocker controversy in the management of hypertension | en_US |
dc.type | A | en_US |
Files
License bundle
1 - 1 of 1